Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ELOVL2 anticorps (N-Term)

ELOVL2 Reactivité: Humain WB, FACS, IHC (p) Hôte: Lapin Polyclonal RB23770 unconjugated
N° du produit ABIN653138
  • Antigène Voir toutes ELOVL2 Anticorps
    ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))
    Épitope
    • 15
    • 8
    • 7
    • 7
    • 5
    • 1
    • 1
    • 1
    AA 1-27, N-Term
    Reactivité
    • 30
    • 16
    • 1
    Humain
    Hôte
    • 45
    Lapin
    Clonalité
    • 45
    Polyclonal
    Conjugué
    • 11
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ELOVL2 est non-conjugé
    Application
    • 31
    • 23
    • 17
    • 13
    • 13
    • 13
    • 5
    • 3
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Homologie
    M
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This ELOVL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-27 amino acids from the N-terminal region of human ELOVL2.
    Clone
    RB23770
    Isotype
    Ig Fraction
  • Indications d'application
    WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Date de péremption
    6 months
  • Meller, VAN Ellen, Gevensleben, Bicker, Hankeln, Gorr, Sailer, Dröge, Schröck, Bootz, Schröck, Perner, Dietrich, Kristiansen: "Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients." dans: Anticancer research, Vol. 36, Issue 12, pp. 6235-6241, (2017) (PubMed).

  • Antigène
    ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))
    Autre désignation
    ELOVL2 (ELOVL2 Produits)
    Synonymes
    anticorps AI317360, anticorps Ssc2, anticorps SSC2, anticorps elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2, anticorps ELOVL fatty acid elongase 2, anticorps Elovl2, anticorps ELOVL2
    Sujet
    ELOVL2 could be implicated in tissue-specific synthesis of very long chain fatty acids and sphingolipids. This protein may catalyze one or both of the reduction reaction in fatty acid elongation, i.e., conversion of beta-ketoacyl CoA to beta-hydroxyacyl CoA or reduction of trans-2-enoyl CoA to the saturated acyl CoA derivative (By similarity).
    Poids moléculaire
    34585
    ID gène
    54898
    NCBI Accession
    NP_060240
    UniProt
    Q9NXB9
Vous êtes ici:
Support technique